[11C]SB-207145

N/A

Report date: 2025/11/24 11:49:27
NME

Base Information

Drug Name[11C]SB-207145
Drug Alias Name[11C]SB-207145
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Carbon > 11CRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of Action5-HT4 receptor ligands
TargetsSerotonin 4 (5-HT4) receptor
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsDiagnostic agents

Other Information

ATC CodeN/A
Related LinksN/A